BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $12.46 million. The enterprise value is -$589,593.
Important Dates
The next estimated earnings date is Friday, March 28, 2025, before market open.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 6.92 million shares outstanding. The number of shares has increased by 74.26% in one year.
| Current Share Class | 6.92M |
| Shares Outstanding | 6.92M |
| Shares Change (YoY) | +74.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 20.57% |
| Owned by Institutions (%) | 4.07% |
| Float | 4.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.97 |
| Forward PS | 5.04 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.95 |
| Quick Ratio | 2.89 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.56% and return on invested capital (ROIC) is -65.51%.
| Return on Equity (ROE) | -84.56% |
| Return on Assets (ROA) | -53.24% |
| Return on Invested Capital (ROIC) | -65.51% |
| Return on Capital Employed (ROCE) | -120.96% |
| Revenue Per Employee | $34,273 |
| Profits Per Employee | -$877,021 |
| Employee Count | 11 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.14% in the last 52 weeks. The beta is 61.97, so BRTX's price volatility has been higher than the market average.
| Beta (5Y) | 61.97 |
| 52-Week Price Change | +24.14% |
| 50-Day Moving Average | 1.90 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 37.55 |
| Average Volume (20 Days) | 812,727 |
Short Selling Information
The latest short interest is 235,593, so 3.40% of the outstanding shares have been sold short.
| Short Interest | 235,593 |
| Short Previous Month | 130,205 |
| Short % of Shares Out | 3.40% |
| Short % of Float | 5.43% |
| Short Ratio (days to cover) | 3.29 |
Income Statement
In the last 12 months, BRTX had revenue of $377,000 and -$9.65 million in losses. Loss per share was -$1.40.
| Revenue | 377,000 |
| Gross Profit | 352,267 |
| Operating Income | -12.09M |
| Pretax Income | -6.96M |
| Net Income | -9.65M |
| EBITDA | -11.90M |
| EBIT | -12.09M |
| Loss Per Share | -$1.40 |
Full Income StatementBalance Sheet
The company has $13.09 million in cash and $42,414 in debt, giving a net cash position of $13.05 million or $1.89 per share.
| Cash & Cash Equivalents | 13.09M |
| Total Debt | 42,414 |
| Net Cash | 13.05M |
| Net Cash Per Share | $1.89 |
| Equity (Book Value) | 9.99M |
| Book Value Per Share | 1.44 |
| Working Capital | 8.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.47 million and capital expenditures -$163,779, giving a free cash flow of -$7.63 million.
| Operating Cash Flow | -7.47M |
| Capital Expenditures | -163,779 |
| Free Cash Flow | -7.63M |
| FCF Per Share | -$1.10 |
Full Cash Flow StatementMargins
| Gross Margin | 93.44% |
| Operating Margin | -3,205.76% |
| Pretax Margin | -2,558.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.26% |
| Shareholder Yield | -74.26% |
| Earnings Yield | -77.45% |
| FCF Yield | -61.29% |
Analyst Forecast
The average price target for BRTX is $18.00, which is 900.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.00 |
| Price Target Difference | 900.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 244.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 0.00025:1.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.00025:1 |
Scores
BRTX has an Altman Z-Score of -15.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.51 |
| Piotroski F-Score | 2 |